Generali Investments Towarzystwo Funduszy Inwestycyjnych Bristol Myers Squibb CO Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $157 Billion
- Q1 2025
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 4,600 shares of BMY stock, worth $230,276. This represents 0.18% of its overall portfolio holdings.
Number of Shares
4,600
Previous 4,600
-0.0%
Holding current value
$230,276
Previous $260 Million
7.83%
% of portfolio
0.18%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,788Shares Held
1.57BCall Options Held
27.4MPut Options Held
27.8M-
Vanguard Group Inc Valley Forge, PA191MShares$9.58 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.94 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.81 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.76 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.6MShares$3.03 Billion0.71% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $106B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...